Associated Papers
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.
Woyach JA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
37314786 (PubMed )
Supplement: ccr-22-3887_supplementary_table_s2_suppts2.pdf
Select a paper to view details